Drug Profile
APR 102
Alternative Names: SP-SAP; Substance P-SaporinLatest Information Update: 28 Dec 2022
Price :
$50
*
At a glance
- Originator Advanced Pain Therapeutics LLC
- Developer Advanced Pain Remedies; University of Texas Southwestern Medical Center
- Class Analgesics; Anti-inflammatories; Biological proteins; Biological toxins; Drug conjugates; Immunotoxins; Neuropeptides; Peptides; Proteins
- Mechanism of Action Protein synthesis inhibitors; Ribosomal protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Dec 2022 Discontinued - Phase-I for Pain in USA (Intrathecal)
- 28 May 2020 No recent reports of development identified for phase-I development in Pain in USA (Intrathecal, Injection)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pain in USA (Intrathecal, Injection)